vimarsana.com
Home
Live Updates
Pivotal Clinical SAHARA Study Shows Candesant Biomedical's I
Pivotal Clinical SAHARA Study Shows Candesant Biomedical's I
Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...
Related Keywords
Louisiana ,
United States ,
Eastern Virginia Medical School ,
Virginia ,
New Orleans ,
Canada ,
Americans ,
Canadian ,
American ,
Suzanne Haber ,
David Pariser ,
Virginia Clinical Research Inc ,
International Hyperhidrosis Society ,
Drug Administration ,
Office Treatment ,
Candesant Biomedical Inc ,
Consumer Survey On Cosmetic Dermatologic Procedures ,
American Society For Dermatologic Surgery ,
Sweat Solutions ,
Canadian Hyperhidrosis Advisory Committee ,
American Academy Of Dermatology ,
Eastern Virginia Medical School Department Of Dermatology ,
Study Endpoints ,
American Academy ,
Hyperhidrosis Disease Severity Scale ,
Eastern Virginia Medical School Department ,
Virginia Clinical Research ,
International Hyperhidrosis ,
American Society ,
Dermatologic Surgery ,
Excessive Axillary Sweating ,
Primary Axillary ,
Pilot Study ,
Novel Device ,
Subjects With Axillary ,
Canadian Hyperhidrosis Advisory ,
Arch Dermatol Res ,
Under Age ,
Cosmetic Dermatologic ,
Press Release ,
Accessed Feb ,
Candesant Biomedical ,
Nc ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Clinical Trials Amp Medical Discoveries ,